Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Biohaven Ltd. (BHVN)

(Delayed Data from NYSE)

$34.71 USD

-0.38 (-1.08%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $34.71 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

Top 37% (91 out of 249)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

View Cart/Checkout

Biohaven Ltd. [BHVN]

Reports for Purchase

Showing records 181 - 200 ( 271 total )

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 181

10/23/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker - Week Ending 10/16/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 182

10/21/2020

Pages: 14

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 183

10/21/2020

Pages: 14

More Than Migraine: Management Call Provides Deep Dive Into BHVN Story

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 184

10/19/2020

Pages: 30

It''s That Time Again; 3Q20 Commercial Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 185

10/16/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 186

10/14/2020

Pages: 4

Prevention Filing - CHECK; Looking Ahead to Mid-Year Nurtec ODT PDUFA

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 10.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 187

10/13/2020

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 188

10/13/2020

Pages: 15

Survey Says... Continue to Receive Positive Nurtec ODT Physician Feedback

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 189

10/13/2020

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 190

10/09/2020

Industry Report

Pages: 21

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 191

10/02/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 192

09/29/2020

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 193

09/25/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker - Week Ending 9/18/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 194

09/18/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 195

09/11/2020

Industry Report

Pages: 23

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 196

09/04/2020

Pages: 10

Revisiting Recent Financings - Updating Model

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 197

09/04/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 198

09/04/2020

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 199

08/28/2020

Industry Report

Pages: 21

Neurology Prescription Sales Tracker - Week Ending 8/21/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Biohaven Ltd.

Industry: Medical - Biomedical and Genetics

Record: 200

08/27/2020

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

previous
1
2
...
6
7
8
9
10
11
12
13
14
next